Nimotuzumab [Theraloc] granted orphan drug status in Europe.

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1636, 2008-01, pp. : 23-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rexin-G granted orphan drug status for third indication in US.

By  

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pfizer's SU 11248 has been granted orphan drug status by the European Commission

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

ARC 1779 granted orphan status for TTP in the US.

By  

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

US orphan drug designation granted for MGCD0103

By  

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The European Commission has granted orphan drug designation to CytRx Corporation's arimoclomol for the treatment of amyotrophic lateral sclerosis

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite